Effect of fluticasone propionate–salmeterol therapy on seasonal changes in airway responsiveness and exhaled nitric oxide levels in patients with pollen-induced asthma
- 1 November 2005
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 95 (5) , 452-461
- https://doi.org/10.1016/s1081-1206(10)61171-4
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Can Guideline-defined Asthma Control Be Achieved?American Journal of Respiratory and Critical Care Medicine, 2004
- Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroidsEuropean Respiratory Journal, 2002
- A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammationJournal of Allergy and Clinical Immunology, 2000
- Effect of Long-Term Salmeterol Treatment on Exercise-Induced AsthmaNew England Journal of Medicine, 1998
- Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.Thorax, 1998
- Tolerance to the Protective Effect of Salmeterol on Allergen ChallengeChest, 1996
- Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients.American Journal of Respiratory and Critical Care Medicine, 1996
- Tolerance to the Nonbronchodilator Effects of Inhaled β2-Agonists in AsthmaNew England Journal of Medicine, 1992
- Long-Term Effects of a Long-Acting β2-Adrenoceptor Agonist, Salmeterol, on Airway Hyperresponsiveness in Patients with Mild AsthmaNew England Journal of Medicine, 1992
- Isolated Bronchi from Asthmatics Are Hyperresponsive to Adenosine, which Apparently Acts Indirectly by Liberation of Leukotrienes and HistamineAmerican Review of Respiratory Disease, 1992